logo-loader
RNS
Catenae Innovation PLC

Catenae Innov. PLC - Issue of Warrants

RNS Number : 3283C
Catenae Innovation PLC
16 October 2020
 

 

Catenae Innovation PLC

("Catenae", the "Company" or the "Group")

 

Issue of Warrants

 

Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology, announces that, further to the announcement made on 16 October 2020, the Company has agreed to issue warrants over 10,000,000 new ordinary shares in the Company (the "Warrants") to a related party of BHA-Medical (Pty) Limited ("BHA-Medical").

 

Furthermore, a warrant over 2,000,000 new ordinary shares in the Company (also defined as the "Warrants") will also be issued to other parties on the same terms as BHA-Medical, as detailed below.

 

The Warrants will be exercisable at a price of 2.5 pence per ordinary share and will vest with immediate effect from the date of grant and may be exercised for a period of up to 2 years from issue.  A further announcement will be made when the Warrants are issued.

 

Following the issue of Warrants, the Company will have 58,354,769 warrants in issue, representing 26.4% of the issued ordinary share capital.

 

The Company's issued share capital comprises 221,091,508 Ordinary Shares of 0.2p.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The person who arranged for release of this announcement on behalf of the Company was Guy Meyer, Chief Executive Officer of the Company.

 

- Ends -

 

 

For further information please contact:

 

Catenae Innovation PLC

+44 (0)191 580 8545

Guy Meyer, Chief Executive Officer


 

Cairn Financial Advisers LLP (Nominated Adviser)

+44(0)20 7213 0880

Liam Murray / Jo Turner




Brandon Hill Capital Limited, Broker

+44 (0)20 3463 5000

Andy Gutmann

 



Yellow Jersey PR (PR & IP)

+44 (0)20 3004 9512

Sarah Hollins / Annabel Atkins


 

Notes to Editors:

 

About Catenae Innovation PLC

 

Catenae Innovation is an AIM quoted provider of digital media and technology services. Catenae use the power of blockchain to deliver solutions where its people-centric technology enables trust and certainty allowing organisations to gain better control over their operations, manage staff and safely welcome customers.

 

www.catenaeinnovation.com

 

Forward-Looking Statements

Certain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements.

 

The Company cautions security holders and prospective security holders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances, or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEGRBDGBSBDGGL
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE

4 min read